Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
39
MEDP Quote, Financials, Valuation and Earnings
Last price:
$453.86
Seasonality move
:
-6.34%
Day range:
$440.93 - $454.71
52-week range:
$250.05 - $628.92
Dividend yield:
0%
P/E ratio:
29.67x
P/S ratio:
5.30x
P/B ratio:
28.05x
Volume:
394.1K
Avg. volume:
378.1K
1-year change:
31.58%
Market cap:
$12.9B
Revenue:
$2.5B
EPS (TTM):
$15.29
Analysts' Opinion
-
Consensus RatingMedpace Holdings, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 7 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $486.92, Medpace Holdings, Inc. has an estimated upside of 7.31% from its current price of $453.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $329.00 representing 100% downside risk from its current price of $453.77.
Fair Value
-
According to the consensus of 11 analysts, Medpace Holdings, Inc. has 7.31% upside to fair value with a price target of $486.92 per share.
MEDP vs. S&P 500
-
Over the past 5 trading days, Medpace Holdings, Inc. has overperformed the S&P 500 by 7.91% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Medpace Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medpace Holdings, Inc. has grown year-over-year revenues for 22 quarters straight. In the most recent quarter Medpace Holdings, Inc. reported revenues of $708.5M.
Earnings Growth
-
Medpace Holdings, Inc. has grown year-over-year earnings for 16 quarters straight. In the most recent quarter Medpace Holdings, Inc. reported earnings per share of $4.67.
Enterprise value:
12.5B
EV / Invested capital:
--
Price / LTM sales:
5.30x
EV / EBIT:
23.40x
EV / Revenue:
4.95x
PEG ratio (5yr expected):
1.41x
EV / Free cash flow:
18.36x
Price / Operating cash flow:
19.65x
Enterprise value / EBITDA:
22.23x
Gross Profit (TTM):
$732.5M
Return On Assets:
24.26%
Net Income Margin (TTM):
17.83%
Return On Equity:
96.22%
Return On Invested Capital:
73.36%
Operating Margin:
21.63%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $1.9B | $2.1B | $2.5B | $536.6M | $708.5M | |
| Gross Profit | $498.2M | $627.1M | $732.5M | $170.8M | $198.2M | |
| Operating Income | $336.8M | $446.9M | $534.9M | $125.4M | $153.3M | |
| EBITDA | $372.8M | $476.1M | $563.1M | $132.9M | $160.4M | |
| Diluted EPS | $8.88 | $12.63 | $15.29 | $3.67 | $4.67 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $690.9M | $334M | $593.8M | $1B | $989.6M | |
| Total Assets | $1.7B | $1.4B | $1.7B | $2.1B | $2B | |
| Current Liabilities | $557.2M | $803.5M | $925.1M | $1.1B | $1.3B | |
| Total Liabilities | $707M | $966.1M | $1.1B | $1.3B | $1.5B | |
| Total Equity | $952.9M | $386.4M | $559M | $825.5M | $459.1M | |
| Total Debt | $131M | $138.9M | $142.1M | $126.2M | $113.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $433.4M | $608.8M | $713.2M | $190.7M | $192.7M | |
| Cash From Investing | -$34.6M | -$28.3M | -$31.1M | -$7.6M | -$4.5M | |
| Cash From Financing | -$182.6M | -$154M | -$860.4M | -$168.6M | $22.7M | |
| Free Cash Flow | $396.7M | $572.3M | $681.9M | $183M | $188.1M | |
MEDP
Sector
Market Cap
$12.9B
$25.5M
Price % of 52-Week High
72.15%
49.47%
Dividend Yield
0%
0%
Shareholder Yield
5.42%
-1.77%
1-Year Price Total Return
31.59%
-21.96%
Beta (5-Year)
1.422
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$436.08
200-day SMA
Sell
Level
$472.96
Bollinger Bands (100)
Sell
Level
514.75 - 609.01
Chaikin Money Flow
Buy
Level
29.8M
20-day SMA
Sell
Level
$519.32
Relative Strength Index (RSI14)
Sell
Level
30.81
ADX Line
Sell
Level
38.65
Williams %R
Neutral
Level
-70.1163
50-day SMA
Sell
Level
$557.14
MACD (12, 26)
Sell
Level
-40.80
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
45.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.9382)
Buy
CA Score
(Annual)
Level (0.3571)
Buy
Beneish M-Score
(Annual)
Level (-2.8731)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.0818)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Stock Forecast FAQ
In the current month, MEDP has received 3 Buy ratings 7 Hold ratings, and 1 Sell ratings. The MEDP average analyst price target in the past 3 months is $486.92.
-
Where Will Medpace Holdings, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medpace Holdings, Inc. share price will rise to $486.92 per share over the next 12 months.
-
What Do Analysts Say About Medpace Holdings, Inc.?
Analysts are divided on their view about Medpace Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medpace Holdings, Inc. is a Sell and believe this share price will drop from its current level to $329.00.
-
What Is Medpace Holdings, Inc.'s Price Target?
The price target for Medpace Holdings, Inc. over the next 1-year time period is forecast to be $486.92 according to 11 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is MEDP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medpace Holdings, Inc. is a Hold. 7 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MEDP?
You can purchase shares of Medpace Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medpace Holdings, Inc. shares.
-
What Is The Medpace Holdings, Inc. Share Price Today?
Medpace Holdings, Inc. was last trading at $453.86 per share. This represents the most recent stock quote for Medpace Holdings, Inc.. Yesterday, Medpace Holdings, Inc. closed at $453.77 per share.
-
How To Buy Medpace Holdings, Inc. Stock Online?
In order to purchase Medpace Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MEDP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MEDP
Sector
P/E ratio
29.67x
23.41x
PEG ratio
1.41x
-0.01x
P/B ratio
28.05x
1.78x
Price / LTM sales
5.30x
1.56x
Growth Metrics
MEDP
Sector
Revenue growth
32.03%
3.51%
Earnings growth
27.08%
9.95%
Revenue (5-year growth)
22.27%
6.45%
Earnings forecast
$4.09
-$0.19
Profitability
MEDP
Sector
Profitability FY 2025
$732.5M
$2.6M
Return on invested capital
73.36%
-33.25%
Return on assets
24.26%
-29.68%
Return on equity
96.22%
-38.71%
Earnings Date
Last Earnings Date
Feb
9
Next Earnings Date
Apr
20
Estimated Next Earnings Date
May
11
Balance Sheet
MEDP
Sector
Total cash
$497M
$25M
Short term investments
--
$24M
Total assets
$2B
$71.9M
Long term debt
$113.6M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
